Robert Andrew Douglas net worth and biography

Robert Douglas Biography and Net Worth

COO of ResMed

Robert Douglas was appointed ResMed’s president in March 2013 and chief operating officer in September 2011; together with ResMed chief executive officer, Mick Farrell, he holds full operational responsibility for ResMed and its subsidiaries.

Previously, Rob was ResMed’s chief operating officer of Asia Pacific and global supply chain from 2008 through 2011, responsible for the region’s commercial distribution, sales operations, and global manufacturing; Sydney chief operating officer from 2005 through 2008, responsible for the company’s manufacturing and research and development; vice president of operations from 2003 to 2005, responsible for the company’s manufacturing; vice president of ResMed’s respiratory and cardiac business from 2002 to 2003; and vice president of corporate marketing when he joined ResMed in 2001.

Rob serves on the board of directors of Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, since December 2019, and is a member of the Audit Committee. He also serves as co-vice chairman on the Board of Directors of the San Diego Regional Economic Development Corporation, as well as vice chairman on the Board of Directors of EvoNexus, a non-profit technology incubator.

Rob has a Master of Business Administration from Macquarie University, a bachelor’s in electrical engineering with first-class honors, and a Bachelor of Science in computer sciences from the University of New South Wales, Sydney.

What is Robert Andrew Douglas' net worth?: The estimated net worth of Robert Andrew Douglas is at least $53.51 million as of August 15th, 2023. Mr. Douglas owns 250,526 shares of ResMed stock worth more than $53,509,347 as of April 13th. This net worth evaluation does not reflect any other assets that Mr. Douglas may own. Learn More about Robert Andrew Douglas' net worth.
How do I contact Robert Andrew Douglas?: The corporate mailing address for Mr. Douglas and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at investorrelations@resmed.com. Learn More on Robert Andrew Douglas' contact information.
Has Robert Andrew Douglas been buying or selling shares of ResMed?: Robert Andrew Douglas has not been actively trading shares of ResMed during the last quarter. Most recently, Robert Andrew Douglas sold 1,500 shares of the business's stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $181.01, for a transaction totalling $271,515.00. Following the completion of the sale, the chief operating officer now directly owns 250,526 shares of the company's stock, valued at $45,347,711.26. Learn More on Robert Andrew Douglas' trading history.
Who are ResMed's active insiders?: ResMed's insider roster includes Carol Burt (Director), Jan De Witte (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.
Are insiders buying or selling shares of ResMed?: In the last twelve months, insiders at the medical equipment provider sold shares 36 times. They sold a total of 230,820 shares worth more than $51,863,480.29. The most recent insider tranaction occured on April, 7th when CEO Michael J Farrell sold 8,009 shares worth more than $1,680,688.65. Insiders at ResMed own 0.7% of the company. Learn More about insider trades at ResMed.
Information on this page was last updated on 4/7/2025.

Robert Andrew Douglas Insider Trading History at ResMed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2023	Sell	1,500	$181.01	$271,515.00	250,526
7/17/2023	Sell	1,500	$222.22	$333,330.00	252,026
6/15/2023	Sell	1,500	$216.27	$324,405.00	253,526
5/15/2023	Sell	1,500	$232.85	$349,275.00	255,026
4/17/2023	Sell	1,500	$224.65	$336,975.00	256,526
3/15/2023	Sell	1,500	$206.14	$309,210.00	258,026
2/15/2023	Sell	1,500	$213.50	$320,250.00	261,445
1/17/2023	Sell	1,500	$220.43	$330,645.00	226,208
11/15/2022	Sell	11,280	$222.07	$2,504,949.60	40,186
10/14/2022	Sell	11,355	$215.09	$2,442,346.95	35,086
9/15/2022	Sell	11,189	$232.51	$2,601,554.39	28,408
4/18/2022	Sell	8,000	$233.29	$1,866,320.00	17,175
3/15/2022	Sell	8,000	$238.07	$1,904,560.00
1/18/2022	Sell	8,000	$247.80	$1,982,400.00
12/15/2021	Sell	8,000	$256.52	$2,052,160.00
11/15/2021	Sell	8,000	$271.75	$2,174,000.00
10/15/2021	Sell	8,000	$255.77	$2,046,160.00
9/15/2021	Sell	8,000	$291.83	$2,334,640.00
8/16/2021	Sell	8,000	$275.57	$2,204,560.00	24,767
7/15/2021	Sell	8,000	$248.00	$1,984,000.00
7/15/2021	Sell	8,000	$248.00	$1,984,000.00
5/17/2021	Sell	8,000	$195.00	$1,560,000.00	8,766
4/15/2021	Sell	964	$207.45	$199,981.80	16,701
3/15/2021	Sell	1,081	$185.48	$200,503.88	16,701
1/15/2021	Sell	938	$212.86	$199,662.68	12,602
11/24/2020	Sell	955	$211.00	$201,505.00	12,603
10/15/2020	Sell	1,125	$176.72	$198,810.00	24,620
9/15/2020	Sell	1,147	$175.49	$201,287.03	24,620
7/15/2020	Sell	1,026	$196.98	$202,101.48	24,620
6/15/2020	Sell	1,245	$158.79	$197,693.55	24,620
4/15/2020	Sell	1,222	$159.03	$194,334.66	24,544
2/18/2020	Sell	1,133	$176.14	$199,566.62	24,544
1/15/2020	Sell	1,264	$158.43	$200,255.52	66,671
12/16/2019	Sell	1,302	$154.71	$201,432.42	66,671
11/18/2019	Sell	1,360	$146.63	$199,416.80
10/15/2019	Sell	3,302	$130.25	$430,085.50	48,716
9/16/2019	Sell	3,307	$131.63	$435,300.41	48,721
8/15/2019	Sell	4,070	$131.12	$533,658.40	48,721
7/15/2019	Sell	4,111	$124.50	$511,819.50	48,721
6/17/2019	Sell	4,154	$118.44	$491,999.76	48,721
5/15/2019	Sell	4,200	$111.35	$467,670.00
4/15/2019	Sell	4,285	$102.29	$438,312.65	48,604
3/15/2019	Sell	4,298	$100.90	$433,668.20	48,604
2/15/2019	Sell	4,313	$99.95	$431,084.35	41,728
1/15/2019	Sell	4,188	$114.18	$478,185.84	41,728
12/17/2018	Sell	4,193	$112.56	$471,964.08	89,605
11/15/2018	Sell	3,307	$101.44	$335,462.08	59,112
1/4/2016	Sell	6,337	$52.97	$335,670.89	31,304
12/1/2015	Sell	6,333	$59.77	$378,523.41	31,304
11/2/2015	Sell	6,333	$57.60	$364,780.80	68,391
10/5/2015	Sell	6,333	$52.13	$330,139.29	68,179
9/3/2015	Sell	6,333	$52.04	$329,569.32	75,316
7/1/2015	Sell	6,333	$56.59	$358,384.47
6/1/2015	Sell	6,333	$59.22	$375,040.26
4/1/2015	Sell	6,333	$70.67	$447,553.11
3/2/2015	Sell	6,333	$64.39	$407,781.87
2/3/2015	Sell	6,333	$62.35	$394,862.55
1/2/2015	Sell	8,000	$56.99	$455,920.00
12/1/2014	Sell	8,000	$52.93	$423,440.00
11/3/2014	Sell	8,000	$51.84	$414,720.00
10/1/2014	Sell	8,000	$49.11	$392,880.00
8/1/2014	Sell	8,000	$48.95	$391,600.00
7/1/2014	Sell	8,000	$50.11	$400,880.00
6/2/2014	Sell	8,000	$50.11	$400,880.00
5/1/2014	Sell	8,000	$49.75	$398,000.00
12/2/2013	Sell	8,000	$49.10	$392,800.00	100,572
10/1/2013	Sell	8,000	$53.20	$425,600.00
9/3/2013	Sell	8,000	$47.51	$380,080.00	123,892
8/1/2013	Sell	8,000	$48.57	$388,560.00
6/3/2013	Sell	8,000	$47.96	$383,680.00
2/4/2013	Sell	8,000	$44.14	$353,120.00

See Full Table

Robert Andrew Douglas Buying and Selling Activity at ResMed

ResMed Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Today's Range

Now: $213.59

$206.74

$214.00

50 Day Range

MA: $225.64

$204.54

$242.19

2 Week Range

Now: $213.59

$172.19

$263.05

Volume

2,305,933 shs

Average Volume

1,024,231 shs

Market Capitalization

$31.37 billion

P/E Ratio

25.22

Dividend Yield

0.98%

Beta

0.75